MAZZOLARI, ANGELICA
 Distribuzione geografica
Continente #
AS - Asia 2.589
NA - Nord America 2.537
EU - Europa 2.393
SA - Sud America 280
AF - Africa 66
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.873
Nazione #
US - Stati Uniti d'America 2.477
CN - Cina 857
SG - Singapore 793
IT - Italia 676
GB - Regno Unito 535
HK - Hong Kong 279
RU - Federazione Russa 206
SE - Svezia 203
DE - Germania 202
BR - Brasile 201
FR - Francia 148
IN - India 130
VN - Vietnam 115
BD - Bangladesh 114
NL - Olanda 99
IE - Irlanda 66
FI - Finlandia 65
TR - Turchia 61
ID - Indonesia 57
KR - Corea 57
DK - Danimarca 52
CA - Canada 33
JP - Giappone 32
CI - Costa d'Avorio 24
AR - Argentina 20
PL - Polonia 20
UA - Ucraina 19
AT - Austria 18
CO - Colombia 17
MX - Messico 15
ES - Italia 14
CH - Svizzera 13
CL - Cile 13
BE - Belgio 12
PK - Pakistan 12
EC - Ecuador 11
EU - Europa 9
GR - Grecia 9
IQ - Iraq 9
SA - Arabia Saudita 9
VE - Venezuela 9
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
AU - Australia 7
PH - Filippine 7
TW - Taiwan 6
UZ - Uzbekistan 6
IR - Iran 5
KZ - Kazakistan 5
MA - Marocco 5
CR - Costa Rica 4
HU - Ungheria 4
MY - Malesia 4
SC - Seychelles 4
AL - Albania 3
IL - Israele 3
LU - Lussemburgo 3
PE - Perù 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TN - Tunisia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BW - Botswana 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HR - Croazia 2
KE - Kenya 2
LT - Lituania 2
LV - Lettonia 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TG - Togo 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
GE - Georgia 1
GI - Gibilterra 1
GY - Guiana 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 7.875
Città #
Southend 468
Singapore 439
Milan 279
Ashburn 273
Hong Kong 252
Chandler 195
Beijing 166
San Jose 160
Council Bluffs 143
Wilmington 94
Dallas 91
Los Angeles 87
Princeton 87
Fairfield 85
Seattle 80
Santa Clara 79
New York 71
Ann Arbor 69
Dublin 64
Boardman 49
Dearborn 48
Hefei 47
Lauterbourg 46
Nanjing 42
Jakarta 41
Guangzhou 38
Moscow 38
Houston 37
Bengaluru 35
Ho Chi Minh City 35
The Dalles 35
Frankfurt am Main 34
Woodbridge 34
Seoul 31
Buffalo 30
Cambridge 29
Helsinki 28
Des Moines 26
Hanoi 26
Varedo 26
Abidjan 24
Columbus 24
Redwood City 24
São Paulo 24
Munich 23
Rome 23
Tokyo 23
Istanbul 21
Shenyang 21
Changsha 18
Atlanta 16
Hanover 16
Phoenix 16
Jinan 15
Berlin 14
Fuzhou 14
Hangzhou 14
London 13
Shanghai 13
Amsterdam 12
Cangzhou 12
Hebei 12
Lappeenranta 12
Nanchang 12
Naples 12
Shenzhen 12
Haiphong 11
Nuremberg 11
Paris 11
San Diego 11
Tianjin 11
Warsaw 11
Bodio Lomnago 10
Siracusa 10
Somerville 10
Toronto 10
Turku 10
Washington 10
Bogotá 9
Brussels 9
Hyderabad 9
Mountain View 9
Redmond 9
Bologna 8
Bühl 8
Falls Church 8
Jiaxing 8
Orem 8
Palermo 8
Vienna 8
Andover 7
Charlotte 7
Chicago 7
Dubai 7
Eitensheim 7
Florence 7
Ningbo 7
Piscataway 7
Rio de Janeiro 7
Tradate 7
Totale 4.674
Nome #
IN SILICO APPROACHES IN DRUG DESIGN AND DEVELOPMENT: APPLICATIONS TO RATIONAL LIGAND DESIGN AND METABOLISM PREDICTION 364
The VEGA suite of programs: a versatile platform for cheminformatics and drug design projects 355
A capture method based on the VC1 domain reveals new binding properties of the human receptor for advanced glycation end products (RAGE) 280
MetaClass, a comprehensive classification system for predicting the occurrence of metabolic reactions based on the MetaQSAR database 259
Rescoring and Linearly Combining: a Highly Effective Consensus Strategy for Virtual Screening Campaigns 240
Cyclo(His-Pro) Exerts Protective Carbonyl Quenching Effects through Its Open Histidine Containing Dipeptides 230
Influence of ionization state on the activation of temocapril by hCES1: a molecular-dynamics study 218
GLORYx : Prediction of the metabolites resulting from phase 1 and phase 2 biotransformations of xenobiotics 217
Repositioning dequalinium as potent muscarinic allosteric ligand by combining virtual screening campaigns and experimental binding assays 216
Carbachol dimers with primary carbamate groups as homobivalent modulators of muscarinic receptors 213
Novel Method for Prioritizing Protein Binding Sites Using Pocket Analysis and MD Simulations 207
Hempseed (Cannabis sativa) Peptide H3 (IGFLIIWV) Exerts Cholesterol-Lowering Effects in Human Hepatic Cell Line 204
Obesity and Type 2 Diabetes: Adiposopathy as a Triggering Factor and Therapeutic Options 194
Prediction of the formation of reactive metabolites by a novel classifier approach based on enrichment factor optimization (EFO) as implemented in the VEGA program 192
MetaQSAR: An Integrated Database Engine to Manage and Analyze Metabolic Data 189
MetaTREE, a novel database focused on metabolic trees, predicts an important detoxification mechanism : The glutathione conjugation 182
The VEGA web service: multipurpose online tools for molecular modelling and docking analyses 173
MetaSpot: A General Approach for Recognizing the Reactive Atoms Undergoing Metabolic Reactions Based on the MetaQSAR Database 171
Tree2c: A flexible tool for enabling model deployment with special focus on cheminformatics applications 168
Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products 166
Computational approaches in the rational design of improved carbonyl quenchers : focus on histidine containing dipeptides 164
In silico prediction of human carboxylesterase-1 (hCES1) metabolism combining docking analyses and MD simulations 159
Pharmacokinetic profile of bilberry anthocyanins in rats and the role of glucose transporters : LC-MS/MS and computational studies 157
Data from docking simulations to develop an efficient strategy able to evaluate the interactions between RAGE and MDA-induced albumin adducts 156
In silico prediction of metabolism by human carboxylesterase-1 (hCES1) combining docking analyses and MD simulations 153
WarpEngine, a Flexible Platform for Distributed Computing Implemented in the VEGA Program and Specially Targeted for Virtual Screening Studies 151
Prediction of UGT-mediated Metabolism Using the Manually Curated MetaQSAR Database 146
What Makes a Paper Be Highly Cited? 60 Years of the Journal of Chemical Information and Modeling 146
Quenching activity of carnosine derivatives towards reactive carbonyl species: Focus on α−(methylglyoxal) and β−(malondialdehyde) dicarbonyls 145
VEGA ZZ : a versatile toolkit for drug design and protein modelling 141
Insights into the structural determinants required for high-affinity binding of chiral cyclopropane-containing ligands to α4β2-nicotinic acetylcholine receptors : an integrated approach to behaviorally active nicotinic ligands 141
Homology modeling and metabolism prediction of human carboxylesterase-2 using docking analyses by GriDock : a parallelized tool based on AutoDock 4.0 138
Approaching Pharmacological Space: Events and Components 136
Serum albumin as a probe for testing the selectivity of irreversible cysteine protease inhibitors : the case of vinyl sulfones 136
Binding space concept : a new approach to enhance the reliability of docking scores and its application to predicting butyrylcholinesterase hydrolytic activity 134
An improved dataset of force fields, electronic and physicochemical descriptors of metabolic substrates 133
Mode of interaction of 1,4-dioxane agonists at the M2 and M3 muscarinic receptor orthosteric sites 132
Improvement of Topical Palmitoylethanolamide Anti-Inflammatory Activity by Pegylated Prodrugs 131
Active Learning Approach for Guiding Site-of-Metabolism Measurement and Annotation 122
Approaching pharmacological space: Events and components 116
Carbachol dimers as homobivalent modulators of muscarinic receptors 111
Enhancing the reliability of GPCR models by accounting for flexibility of their pro-containing helices : The case of the human mAChR1 receptor 110
Impact of the Journal of Chemical Information and Modeling Special Issue on Women in Computational Chemistry 107
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over alpha(1)-adrenoceptor and D-2-like receptor subtypes 102
FAME 3 : Predicting the Sites of Metabolism in Synthetic Compounds and Natural Products for Phase 1 and Phase 2 Metabolic Enzymes 102
Predicting Metabolic Reactions with a Molecular Transformer for Drug Design Optimization 98
Structural Effects of Some Relevant Missense Mutations on the MECP2-DNA Binding : a MD Study Analyzed by Rescore+, a Versatile Rescoring Tool of the VEGA ZZ Program 86
Prediction of UGT-mediated phase II metabolism via ligand- and structure-based predictive models 77
MetaQM: Exploring the Role of QM Calculations in Drug Metabolism Prediction 66
Towards the mode of action of Strobilanthes crispus through integrated computational and experimental analyses 52
PepScorer::RMSD: an improved machine learning scoring function for protein–peptide docking 35
Site-of-Metabolism Prediction with Aleatoric and Epistemic Uncertainty Quantification 11
Metabolite Identification Data in Drug Discovery, Part 2: Site-of-Metabolism Annotation, Analysis, and Exploration for Machine Learning 9
FAME3R: an efficient, practical and reliable open-source tool for predicting phase 1 and phase 2 sites of metabolism 9
Automated Annotation of Sites of Metabolism from Biotransformation Data 7
Totale 8.257
Categoria #
all - tutte 24.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 52 31
2021/2022558 30 43 21 32 38 53 36 24 66 48 64 103
2022/2023772 116 77 70 58 68 137 17 86 64 19 39 21
2023/2024537 22 38 24 29 138 22 35 24 22 47 62 74
2024/20251.467 55 85 34 129 138 84 107 154 57 154 134 336
2025/20263.041 343 195 286 216 291 205 384 176 355 252 338 0
Totale 8.257